Core Viewpoint - The report from CITIC Securities indicates that leading global medical aesthetics companies with established brand strength, proactive global channel expansion, and product innovation are expected to achieve superior growth by Q2 2025 [1] Group 1: Market Dynamics - In the U.S., middle-class demand may continue to face pressure, while competition in the South Korean market is intensifying [1] - Emerging markets in China, Europe, and globally are showing steady growth, contributing positively to the medical aesthetics sector [1] Group 2: Product Trends - Leading companies in botulinum toxin are experiencing more stable growth, with market dynamics shifting towards top-tier players [1] - There is a diversification in filler product categories, with hyaluronic acid facing ongoing pressure, while regenerative materials/PDRN are maintaining high growth [1] - In the equipment category, strong brand products in radiofrequency and ultrasound are expected to sustain their momentum [1] Group 3: Future Outlook - Companies that actively expand globally and invest in new materials and product categories are likely to exhibit strong growth potential and may revise their performance guidance upwards [1] - Regional companies focusing on mature markets may face challenges due to intensified competition and operational pressures [1] - The industry outlook remains positive for leading medical aesthetics companies with established brand presence, as they leverage regional and product category expansions for superior growth [1]